China Antidiabetic Thiazolidinediones Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Antidiabetic Thiazolidinediones Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Antidiabetic Thiazolidinediones Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Antidiabetic Thiazolidinediones Overall Market Size
2.1 China Antidiabetic Thiazolidinediones Market Size: 2021 VS 2027
2.2 China Antidiabetic Thiazolidinediones Revenue, Prospects & Forecasts: 2016-2027
2.3 China Antidiabetic Thiazolidinediones Sales: 2016-2027
3 Company Landscape
3.1 Top Antidiabetic Thiazolidinediones Players in China Market
3.2 Top China Antidiabetic Thiazolidinediones Companies Ranked by Revenue
3.3 China Antidiabetic Thiazolidinediones Revenue by Companies
3.4 China Antidiabetic Thiazolidinediones Sales by Companies
3.5 China Antidiabetic Thiazolidinediones Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antidiabetic Thiazolidinediones Companies in China Market, by Revenue in 2020
3.7 Manufacturers Antidiabetic Thiazolidinediones Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antidiabetic Thiazolidinediones Players in China Market
3.8.1 List of Tier 1 Antidiabetic Thiazolidinediones Companies in China
3.8.2 List of Tier 2 and Tier 3 Antidiabetic Thiazolidinediones Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Antidiabetic Thiazolidinediones Market Size Markets, 2021 & 2027
4.1.2 Rosiglitazone
4.1.3 Pioglitazone
4.2 By Type - China Antidiabetic Thiazolidinediones Revenue & Forecasts
4.2.1 By Type - China Antidiabetic Thiazolidinediones Revenue, 2016-2021
4.2.2 By Type - China Antidiabetic Thiazolidinediones Revenue, 2022-2027
4.2.3 By Type - China Antidiabetic Thiazolidinediones Revenue Market Share, 2016-2027
4.3 By Type - China Antidiabetic Thiazolidinediones Sales & Forecasts
4.3.1 By Type - China Antidiabetic Thiazolidinediones Sales, 2016-2021
4.3.2 By Type - China Antidiabetic Thiazolidinediones Sales, 2022-2027
4.3.3 By Type - China Antidiabetic Thiazolidinediones Sales Market Share, 2016-2027
4.4 By Type - China Antidiabetic Thiazolidinediones Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Antidiabetic Thiazolidinediones Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - China Antidiabetic Thiazolidinediones Revenue & Forecasts
5.2.1 By Application - China Antidiabetic Thiazolidinediones Revenue, 2016-2021
5.2.2 By Application - China Antidiabetic Thiazolidinediones Revenue, 2022-2027
5.2.3 By Application - China Antidiabetic Thiazolidinediones Revenue Market Share, 2016-2027
5.3 By Application - China Antidiabetic Thiazolidinediones Sales & Forecasts
5.3.1 By Application - China Antidiabetic Thiazolidinediones Sales, 2016-2021
5.3.2 By Application - China Antidiabetic Thiazolidinediones Sales, 2022-2027
5.3.3 By Application - China Antidiabetic Thiazolidinediones Sales Market Share, 2016-2027
5.4 By Application - China Antidiabetic Thiazolidinediones Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Overview
6.1.3 Sanofi Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.1.4 Sanofi Antidiabetic Thiazolidinediones Product Description
6.1.5 Sanofi Recent Developments
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Corporation Information
6.2.2 Takeda Pharmaceuticals Overview
6.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.2.4 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product Description
6.2.5 Takeda Pharmaceuticals Recent Developments
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Overview
6.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.3.4 Eli Lilly Antidiabetic Thiazolidinediones Product Description
6.3.5 Eli Lilly Recent Developments
6.4 Merck & Co.
6.4.1 Merck & Co. Corporation Information
6.4.2 Merck & Co. Overview
6.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.4.4 Merck & Co. Antidiabetic Thiazolidinediones Product Description
6.4.5 Merck & Co. Recent Developments
6.5 Novo Nordisk
6.5.1 Novo Nordisk Corporation Information
6.5.2 Novo Nordisk Overview
6.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.5.4 Novo Nordisk Antidiabetic Thiazolidinediones Product Description
6.5.5 Novo Nordisk Recent Developments
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Overview
6.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.6.4 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product Description
6.6.5 Bristol-Myers Squibb Recent Developments
6.7 Pfizer
6.7.1 Pfizer Corporation Information
6.7.2 Pfizer Overview
6.7.3 Pfizer Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.7.4 Pfizer Antidiabetic Thiazolidinediones Product Description
6.7.5 Pfizer Recent Developments
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Overview
6.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.8.4 AstraZeneca Antidiabetic Thiazolidinediones Product Description
6.8.5 AstraZeneca Recent Developments
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Overview
6.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.9.4 GlaxoSmithKline Antidiabetic Thiazolidinediones Product Description
6.9.5 GlaxoSmithKline Recent Developments
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Overview
6.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales and Revenue in China Market (2016-2021)
6.10.4 Boehringer Ingelheim Antidiabetic Thiazolidinediones Product Description
6.10.5 Boehringer Ingelheim Recent Developments
7 China Antidiabetic Thiazolidinediones Production Capacity, Analysis
7.1 China Antidiabetic Thiazolidinediones Production Capacity, 2016-2027
7.2 Antidiabetic Thiazolidinediones Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Antidiabetic Thiazolidinediones Supply Chain Analysis
9.1 Antidiabetic Thiazolidinediones Industry Value Chain
9.2 Antidiabetic Thiazolidinediones Upstream Market
9.3 Antidiabetic Thiazolidinediones Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Antidiabetic Thiazolidinediones Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Antidiabetic Thiazolidinediones in China Market
Table 2. Top Antidiabetic Thiazolidinediones Players in China Market, Ranking by Revenue (2019)
Table 3. China Antidiabetic Thiazolidinediones Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Antidiabetic Thiazolidinediones Revenue Share by Companies, 2016-2021
Table 5. China Antidiabetic Thiazolidinediones Sales by Companies, (K Pcs), 2016-2021
Table 6. China Antidiabetic Thiazolidinediones Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Antidiabetic Thiazolidinediones Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Antidiabetic Thiazolidinediones Product Type
Table 9. List of Tier 1 Antidiabetic Thiazolidinediones Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Antidiabetic Thiazolidinediones Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Rosiglitazone
Table 12. Major Manufacturers of Pioglitazone
Table 13. By Type - China Antidiabetic Thiazolidinediones Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Antidiabetic Thiazolidinediones Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Antidiabetic Thiazolidinediones Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Antidiabetic Thiazolidinediones Sales (K Pcs), 2016-2021
Table 17. By Type - China Antidiabetic Thiazolidinediones Sales (K Pcs), 2022-2027
Table 18. By Application - China Antidiabetic Thiazolidinediones Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Antidiabetic Thiazolidinediones Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Antidiabetic Thiazolidinediones Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Antidiabetic Thiazolidinediones Sales (K Pcs), 2016-2021
Table 22. By Application - China Antidiabetic Thiazolidinediones Sales (K Pcs), 2022-2027
Table 23. Sanofi Corporation Information
Table 24. Sanofi Description and Major Businesses
Table 25. Sanofi Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Sanofi Antidiabetic Thiazolidinediones Product
Table 27. Sanofi Recent Developments
Table 28. Takeda Pharmaceuticals Corporation Information
Table 29. Takeda Pharmaceuticals Description and Major Businesses
Table 30. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product
Table 32. Takeda Pharmaceuticals Recent Developments
Table 33. Eli Lilly Corporation Information
Table 34. Eli Lilly Description and Major Businesses
Table 35. Eli Lilly Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Eli Lilly Antidiabetic Thiazolidinediones Product
Table 37. Eli Lilly Recent Developments
Table 38. Merck & Co. Corporation Information
Table 39. Merck & Co. Description and Major Businesses
Table 40. Merck & Co. Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Merck & Co. Antidiabetic Thiazolidinediones Product
Table 42. Merck & Co. Recent Developments
Table 43. Novo Nordisk Corporation Information
Table 44. Novo Nordisk Description and Major Businesses
Table 45. Novo Nordisk Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Novo Nordisk Antidiabetic Thiazolidinediones Product
Table 47. Novo Nordisk Recent Developments
Table 48. Bristol-Myers Squibb Corporation Information
Table 49. Bristol-Myers Squibb Description and Major Businesses
Table 50. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product
Table 52. Bristol-Myers Squibb Recent Developments
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Major Businesses
Table 55. Pfizer Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Pfizer Antidiabetic Thiazolidinediones Product
Table 57. Pfizer Recent Developments
Table 58. AstraZeneca Corporation Information
Table 59. AstraZeneca Description and Major Businesses
Table 60. AstraZeneca Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. AstraZeneca Antidiabetic Thiazolidinediones Product
Table 62. AstraZeneca Recent Developments
Table 63. GlaxoSmithKline Corporation Information
Table 64. GlaxoSmithKline Description and Major Businesses
Table 65. GlaxoSmithKline Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. GlaxoSmithKline Antidiabetic Thiazolidinediones Product
Table 67. GlaxoSmithKline Recent Developments
Table 68. Boehringer Ingelheim Corporation Information
Table 69. Boehringer Ingelheim Description and Major Businesses
Table 70. Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. Boehringer Ingelheim Antidiabetic Thiazolidinediones Product
Table 72. Boehringer Ingelheim Recent Developments
Table 73. Antidiabetic Thiazolidinediones Production Capacity (K Pcs) of Key Manufacturers in China Market, 2019-2021 (K Pcs)
Table 74. China Antidiabetic Thiazolidinediones Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Antidiabetic Thiazolidinediones Market Opportunities & Trends in China Market
Table 76. Antidiabetic Thiazolidinediones Market Drivers in China Market
Table 77. Antidiabetic Thiazolidinediones Market Restraints in China Market
Table 78. Antidiabetic Thiazolidinediones Raw Materials
Table 79. Antidiabetic Thiazolidinediones Raw Materials Suppliers in China Market
Table 80. Typical Antidiabetic Thiazolidinediones Downstream
Table 81. Antidiabetic Thiazolidinediones Downstream Clients in China Market
Table 82. Antidiabetic Thiazolidinediones Distributors and Sales Agents in China Market
List of FiguresFigure 1. Antidiabetic Thiazolidinediones Product Picture
Figure 2. Antidiabetic Thiazolidinediones Segment by Type
Figure 3. Antidiabetic Thiazolidinediones Segment by Application
Figure 4. China Antidiabetic Thiazolidinediones Market Overview: 2020
Figure 5. China Antidiabetic Thiazolidinediones Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Antidiabetic Thiazolidinediones Revenue, 2016-2027 (US$, Mn)
Figure 7. Antidiabetic Thiazolidinediones Sales in China Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Antidiabetic Thiazolidinediones Revenue in 2020
Figure 9. Rosiglitazone Product Picture
Figure 10. Pioglitazone Product Picture
Figure 11. By Type - China Antidiabetic Thiazolidinediones Sales Market Share, 2016-2027
Figure 12. By Type - China Antidiabetic Thiazolidinediones Revenue Market Share, 2016-2027
Figure 13. By Type - China Antidiabetic Thiazolidinediones Price (USD/Pcs), 2016-2027
Figure 14. Hospitals
Figure 15. Clinics
Figure 16. Other
Figure 17. By Application - China Antidiabetic Thiazolidinediones Sales Market Share, 2016-2027
Figure 18. By Application - China Antidiabetic Thiazolidinediones Revenue Market Share, 2016-2027
Figure 19. By Application - China Antidiabetic Thiazolidinediones Price (USD/Pcs), 2016-2027
Figure 20. Sanofi Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Eli Lilly Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Merck & Co. Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Novo Nordisk Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Pfizer Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. AstraZeneca Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. GlaxoSmithKline Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Boehringer Ingelheim Antidiabetic Thiazolidinediones Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. China Antidiabetic Thiazolidinediones Production Capacity (K Pcs), 2016-2027
Figure 31. Antidiabetic Thiazolidinediones Industry Value Chain
Figure 32. Marketing Channels